HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HCID 60937Erstellt: 27. Oktober 2026
Tiludronic Acid
ACPMD · C08141 · ME-3737 · C1-TMBP · Tiludronic · TILUDRONIC ACID · Tilundronic Acid · Tiludronic acid disodium
https://huagongshe.com/de/chemical/60937
Identifikatoren & physikalische Daten
| CAS No. | 89987-06-4 |
|---|
| Summenformel | C7H9ClO6P2S |
|---|
| Durchschnittliche Molmasse | 318,61 g/mol |
|---|
| Monoisotopische Masse | 317,92835995 g/mol |
|---|
| SMILES | O=P(O)(O)C(Sc1ccc(Cl)cc1)P(=O)(O)O |
|---|
| InChIKey | DKJJVAGXPKPDRL-UHFFFAOYSA-N |
|---|
| PubChem CID | 60937 |
|---|
| ChEMBL | CHEMBL1350 |
|---|
| ChEBI | CHEBI:9598 |
|---|
| EC No. | 618-322-0 |
|---|
| DTXSID | DTXSID10237966 |
|---|
Chemische & physikalische Eigenschaften
| XLogP | -0,3 |
|---|
| Polarare Oberfläche (TPSA) | 140 |
|---|
| H-Brücken-Donoren | 4 |
|---|
| H-Brücken-Akzeptoren | 7 |
|---|
| Frei drehbare Bindungen | 4 |
|---|
| Schwere Atome | 17 |
|---|
| Formalladung | 0 |
|---|
| Komplexität | 324 |
|---|
| Arzneimittel | Pharmaceuticals -> Listed in ZINC15 |
|---|
| LogP (Verteilungskoeffizient) | -0.6 |
|---|
| Löslichkeit | 6.97e+00 g/LH2O: >10mg/mL, clear |
|---|
| Human Drugs | Breast FeedingLactationBisphosphonatesBone Density Conservation AgentsDiphosphonates |
|---|
| Animal Drugs | Pharmaceuticals -> UK Veterinary Medicines Directorate List |
|---|
| Physical Description | Solid |
|---|
| Schmelzpunkt | 174-177 °C |
|---|
| Siedepunkt | 600.7±65.0 °C(Predicted) |
|---|
| Dichte | 1.82±0.1 g/cm3(Predicted) |
|---|
| Lagerbedingungen | room temp |
|---|
| pKa (Säurekonstante) | pK1 10.85pK2 6.90pK3 2.95pK4 1.30(at 25℃) |
|---|
| Aggregatzustand | powder |
|---|
| Farbe | white to off-white |
|---|
| InChI | 1S/C7H9ClO6P2S.2Na.H2O/c8-5-1-3-6(4-2-5)17-7(15(9,10)11)16(12,13)14/h1-4,7H,(H2,9,10,11)(H2,12,13,14)1H2/q2*+1/p-2 |
|---|
| InChIKey | SZVJRJRMQCKFON-UHFFFAOYSA-L |
|---|
| SMILES | O.[Na+].[Na+].OP([O-])(=O)C(Sc1ccc(Cl)cc1)P(O)([O-])=O |
|---|
Sicherheit & Vorschriften
| Drug Induced Liver Injury | Drug-Induced Liver Injury Severity and Toxicity (DILIst)tiludronateDILI NegativeOralDOI:10.1016/j.drudis.2019.09.022 |
|---|
| Effects During Pregnancy and Lactation | ◉ Summary of Use during Lactation |
|---|
| Wassergefährdungsklasse (WGK) | 3 |
|---|
| Lagerklasse | 11 - Combustible Solids |
|---|